Cerenome, Inc. (CNSY)
1.70
-0.04
(-2.30%)
USD |
NASDAQ |
Oct 30, 11:34
Cerenome Price to Book Value : 2.275 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 2.328 |
| October 28, 2026 | 2.328 |
| October 27, 2026 | 2.221 |
| October 26, 2026 | 2.101 |
| October 23, 2026 | 2.194 |
| October 22, 2026 | 2.342 |
| October 21, 2026 | 2.315 |
| October 20, 2026 | 2.248 |
| October 19, 2026 | 2.208 |
| October 16, 2026 | 2.275 |
| October 15, 2026 | 2.516 |
| October 14, 2026 | 2.261 |
| October 13, 2026 | 2.328 |
| October 12, 2026 | 2.422 |
| October 09, 2026 | 2.582 |
| October 08, 2026 | 2.395 |
| October 07, 2026 | 2.188 |
| October 06, 2026 | 2.128 |
| October 05, 2026 | 2.087 |
| October 02, 2026 | 2.141 |
| October 01, 2026 | 2.382 |
| September 30, 2026 | 2.502 |
| September 29, 2026 | 2.489 |
| September 28, 2026 | 2.703 |
| September 25, 2026 | 2.663 |
| Date | Value |
|---|---|
| September 24, 2026 | 2.502 |
| September 23, 2026 | 2.609 |
| September 22, 2026 | 2.716 |
| September 21, 2026 | 2.542 |
| September 18, 2026 | 2.716 |
| September 17, 2026 | 2.716 |
| September 16, 2026 | 2.730 |
| September 15, 2026 | 2.837 |
| September 14, 2026 | 2.904 |
| September 11, 2026 | 3.111 |
| September 10, 2026 | 3.198 |
| September 09, 2026 | 3.332 |
| September 08, 2026 | 3.613 |
| September 04, 2026 | 3.686 |
| September 03, 2026 | 3.988 |
| September 02, 2026 | 3.934 |
| September 01, 2026 | 3.626 |
| August 31, 2026 | 3.773 |
| August 28, 2026 | 4.081 |
| August 27, 2026 | 4.148 |
| August 26, 2026 | 4.041 |
| August 25, 2026 | 4.128 |
| August 24, 2026 | 3.961 |
| August 21, 2026 | 4.108 |
| August 20, 2026 | 4.014 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 6.265 |
| Ernexa Therapeutics, Inc. | 0.7607 |
| ACADIA Pharmaceuticals, Inc. | 2.719 |
| Anika Therapeutics, Inc. | 2.124 |
| Savara, Inc. | 6.949 |
Price to Book Value Related Metrics
| PS Ratio | 2.365 |
| Price | 1.70 |
| Earnings Yield | -259.4% |
| Market Cap | 12.43M |